Abiopharma

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT

Best Gaming Monitor Size Guide (2025)

Best Beginner Camera Models for Photography Enthusiasts in 2025

Smith+Nephew PLC Notification

Investor Alert: Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Class Action

PureTech Health: Notice of Half-Yearly Results

Best Bedroom TV Options in 2025

The Blenders With The Best Reviews In 2025

Best Bird Photography Camera Models for Wildlife Enthusiasts in 2025

New Novartis ESC data highlights strength of cardiovascular portfolio

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting